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The Effectiveness of the Commercial Driver Medical Examination in Screening for
Hypertension
Yutao Li, Advisor: Stephen V. Burks

Abstract

Methods

The Commercial Driver Medical Examination (CDME) is used to assess the
medical fitness of a driver to safely operate a commercial motor vehicle.
Hypertension is a disease that has been shown in prior research to cause reduced
driving safety performance when not properly managed, and it is therefore
important that medical examiners be able to consistently identify it in drivers.
However, the CDME has historically been ineffective at screening drivers with
safety-related diseases. For example, a report from the US Government
Accountability Office showed the existence of a substantial number of drivers
who were deemed eligible by the federal government for full disability benefits
and yet also passed their CDME’s. To address these issues, the Federal Motor
Carrier Safety Administration (FMCSA) instituted the Medical Examiner
Registry and mandatory training programs for examiners. This project uses data
from before these reforms to establish a baseline for comparison to the new
version of the CDME. We compare hypertension as captured in CDME records
to hypertension as captured in medical insurance claims data on the same drivers.
Our initial results indicate that of the 1,320 drivers who were determined from
the insurance data to have hypertension, medical examiners were able to
correctly identify 74% of them as having the condition. This suggests that while
the CDME was moderately successful in screening for hypertension even before
the reforms, there was room for improvement.

We analyzed the data by comparing the incidence of hypertension as captured in
the CDME to the incidence as captured in medical insurance claims for the same
drivers. During the period that our data come from, hypertension was defined
as persistently having systolic blood pressure ≥ 140 or diastolic blood pressure ≥
90.

Data Construction
The Truckers & Turnover Project received approximately 4000 optical scans of
CDME records and University of Minnesota Morris students typed the data into
Excel spreadsheets. There are three ways to determine whether the medical
examiner correctly identified drivers with hypertension. First, in the health
history section of the CDME, the drivers self report whether they have a history
of hypertension and whether they are taking medication for hypertension.
Second, a blood pressure measurement is taken during the examination. Third,
for drivers who are certified to drive for less time than the standard of 2 years,
the medical examiner leaves a comment on why a reduced status was given, and
hypertension may be noted. We used International Classification of Diseases
(Ninth Revision, ICD9) diagnosis codes in the medical insurance claims data and
Clinical Classification Software to determine whether the driver had a claim
including a diagnosis of hypertension.
While working with CDME data that should have contained one line per driver,
we found 51 drivers had two CDMEs. We first dropped exams for which the
driver’s certification status was missing, resulting in 6 duplicate drivers being
dropped. For the remaining 45 drivers, we dropped older exams. Because the
incidence of hypertension only changes between exams for less than 10 duplicate
drivers, this should not have a substantive impact on the analysis results. We then
merged CDME and claims data, giving us a dataset containing 3,073 drivers who
have both CDME and medical insurance records. Finally, we rolled up the
medical insurance data, which comes in the form of multiple lines per claim, to
one line per driver, including ICD9 diagnosis codes.

Using our indicators of hypertension in the CDME and medical insurance
claims, we calculated the sensitivity, specificity, positive predictive value, and
negative predictive value of the CDME for screening for hypertension. These
four statistics are defined as:
• Sensitivity: percent of actual positives identified;
• Specificity: percent of actual negatives identified;
• Positive predictive value: given a positive screening, the percent chance the
screening is correct;
• Negative predictive value: given a negative screening, the percent chance the
screening is correct.
In addition, we repeated the analysis while examining the certification status of
drivers who were identified as having hypertension in the CDME; drivers may
be certified for up to 2 years, but examiners may give a reduced certification
period to drivers whose health does not preclude safe driving but requires close
monitoring. Thus, we analyze not only how often hypertension is caught in the
CDME, but how often medical examiners take action to make sure drivers with
the condition remain fit to drive.

Results and Discussion
Table 1: Incidence of Hypertension in CDME and
Medical Records
CDME
Screening
Positive
Negative
Total

N
1,268
1,805
3,073

Medical Claims data
Positive

Negative

979
341
1,320

289
1,464
1,753

Table 1 shows that the number of positives in the medical claims data (1,320) is
only slightly larger than the number of positives in the CDME (1,268),
suggesting that the CDME is at least moderately effective at screening for
hypertension.
This is confirmed by the results in Table 2. Sensitivity is the probability that the
CDME screening will be positive given that the driver has the disease. Of the
1,320 drivers who were indicated to have hypertension in the claims data, 979
were identified in the CDME, resulting in a sensitivity of 74%. This provides
evidence that the CDME is able to screen for hypertension with moderate
success.

Table 2: Sensitivity, Specificity, Positive Predictive Value,
and Negative Predictive Value

Sensitivity
Specificity
Positive Predictive Value
Negative Predictive Value

W/O
Certification
status
74%
84%
77%
81%

W/
Certification
status
71%
90%
83%
81%

Positive predictive value is the probability the driver has the disease given the
CDME screening is positive. The positive predictive value is 77%. This value
may be lower than what one would expect; however, we speculate that there
are two reasons why this is substantially below 100%: (1) a substantial portion
of drivers who have hypertension don’t have a hypertension-related medical
insurance claim, and (2) a driver’s blood pressure may rise above its typical
level during the CDME.
When we repeat the analysis while examining whether drivers who are
identified as having hypertension in the CDME are given a reduced
certification status, we expect that the sensitivity will fall since both
identifying that the driver has hypertension and giving the driver a reduced
certification status is a more stringent standard. However, the sensitivity falls
only slightly, from 74% to 71%, suggesting that when examiners are aware
that the driver has hypertension, they almost always require more frequent
monitoring of the driver’s health.

Conclusions

Both the FMCSA and the Medical Review Board have recommended screening
for hypertension as a safety-related medical disease during the CDME, but the
CDME has historically been relatively ineffective at screening drivers with
safety-related diseases. However, our findings suggest that the CDME was
moderately successful in screening for hypertension even before the FMCSA’s
reforms, although there is room for improvement.
Future research is needed to examine the effectiveness of the CDME in
screening for hypertension after the initiation of the new Medical Examiner
Registry. The results of this study serve as a benchmark for future work of this
type.
Further studies of this nature are needed. The screening effectiveness of the
CDME may vary across medical conditions, and it is important for the safety of
the public highways that examiners appropriately identify and certify drivers
based on their actual medical fitness to operate commercial motor vehicles.
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